Application of in vivo metabolomics to preclinical/toxicological studies: case study on phenytoin-induced systemic toxicity.
暂无分享,去创建一个
W. Mattes | H. Kamp | E. Fabian | G. Krennrich | B. van Ravenzwaay | T. Walk | V. Strauss | J. Wiemer | R. Looser | B van Ravenzwaay | E Fabian | H Kamp | W Mellert | V Strauss | T Walk | W Mattes | M Herold | R Looser | S Groeters | A Prokoudine | G Krennrich | J Wiemer | P Ruiz-Noppinger | S. Groeters | W. Mellert | M. Herold | A. Prokoudine | P. Ruiz-Noppinger
[1] Cheng Ji,et al. Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis. , 2011, Journal of proteome research.
[2] Ute Roessner,et al. Simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry. , 2000 .
[3] P. Watkins,et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[4] H. Kamp,et al. Influence of strain and sex on the metabolic profile of rats in repeated dose toxicological studies. , 2009, Toxicology letters.
[5] B. van Ravenzwaay,et al. The kinetics of nuclear polyploidization and tumour formation in livers of CF-1 mice exposed to dieldrin. , 1987, Carcinogenesis.
[6] H. Kamp,et al. Nutritional impact on the plasma metabolome of rats. , 2011, Toxicology letters.
[7] Abraham Nyska,et al. Discovery of Metabolomics Biomarkers for Early Detection of Nephrotoxicity , 2009, Toxicologic pathology.
[8] Xidong Jin,et al. Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. , 2004, Mutation research.
[9] E. Björnsson. Hepatotoxicity associated with antiepileptic drugs , 2008, Acta neurologica Scandinavica.
[10] H. Kamp,et al. Metabolite profiling in rat plasma as a potential new tool for the assessment of chemically induced toxicity. , 2010 .
[11] Hennicke Kamp,et al. The Use of Metabolomics in Cancer Research , 2010 .
[12] C. F. Wilkinson,et al. Thyroid follicular cell carcinogenesis. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[13] S. Yasuda,et al. Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine. , 2002, Journal of analytical toxicology.
[14] Peng Li,et al. Gene expression analysis of peroxisome proliferators- and phenytoin-induced hepatotoxicity using cDNA microarray. , 2004, The Journal of veterinary medical science.
[15] John C. Lindon,et al. Toxicological applications of magnetic resonance , 2004 .
[16] B. van Ravenzwaay,et al. The use of metabolomics for the discovery of new biomarkers of effect. , 2007, Toxicology letters.
[17] B. van Ravenzwaay,et al. Investigations on cell proliferation and enzyme induction in male rat kidney and female mouse liver caused by tetrahydrofuran. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[18] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[19] D. Wishart. Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.
[20] M. Moore,et al. Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. , 1980, British journal of clinical pharmacology.
[21] G. Anderson. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs , 2004, Neurology.
[22] R. Cox,et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.
[23] Richard D Beger,et al. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. , 2010, Toxicology and applied pharmacology.
[24] H. Kamp,et al. Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. , 2012, Mutation research.
[25] James L Stevens,et al. Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here? , 2006, Chemical research in toxicology.
[26] C. Capen,et al. Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia , 2005, Human & experimental toxicology.
[27] H. Kamp,et al. Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies. , 2012, Toxicology letters.
[28] M. Smythe,et al. Phenytoin Hepatotoxicity: A Review of the Literature , 1989, DICP : the annals of pharmacotherapy.
[29] F. Vargas,et al. In Vivo and In Vitro Effects of Phenytoin (PHT) on ATPases and [14C]‐PHT Binding in Synaptosomes and Mitochondria from Rat Cerebral Cortex , 1994, Epilepsia.
[30] J. George,et al. Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic Drugs , 2002, Seminars in liver disease.
[31] U. Roessner,et al. Technical advance: simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry. , 2000, The Plant journal : for cell and molecular biology.
[32] A. Levin,et al. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. , 1989, Toxicology and applied pharmacology.